[go: up one dir, main page]

MX2015009037A - Enjuague nasal con miel. - Google Patents

Enjuague nasal con miel.

Info

Publication number
MX2015009037A
MX2015009037A MX2015009037A MX2015009037A MX2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A
Authority
MX
Mexico
Prior art keywords
honey
nasal rinse
nasal
carrier
methods
Prior art date
Application number
MX2015009037A
Other languages
English (en)
Inventor
Roland Clifford Park
Kenneth Gene Rayl
Ian Joseph Alexander
Original Assignee
Ent Associates Of Los Alamos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ent Associates Of Los Alamos Llc filed Critical Ent Associates Of Los Alamos Llc
Publication of MX2015009037A publication Critical patent/MX2015009037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones de enjuague nasal novedosas. El enjuague nasal comprende un particulado deshidratado compuesto de miel y un portador. La composición puede ser una composición co-procesada en donde la miel y el portador se combinan mientras que la miel está en forma líquida y se procesan conjuntamente para producir el particulado deshidratado. También se proporcionan métodos para producir las composiciones de enjuague nasal, así como métodos de uso de las composiciones de enjuague nasal para la prevención o tratamiento de infección nasal, rinitis o sinusitis.
MX2015009037A 2013-01-14 2014-01-14 Enjuague nasal con miel. MX2015009037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361752053P 2013-01-14 2013-01-14
PCT/US2014/011500 WO2014110580A1 (en) 2013-01-14 2014-01-14 Honey nasal rinse

Publications (1)

Publication Number Publication Date
MX2015009037A true MX2015009037A (es) 2016-07-13

Family

ID=51165297

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009037A MX2015009037A (es) 2013-01-14 2014-01-14 Enjuague nasal con miel.

Country Status (8)

Country Link
US (3) US20140199266A1 (es)
EP (1) EP2943252A1 (es)
JP (1) JP2016505022A (es)
CN (1) CN105658281A (es)
AU (1) AU2014205065A1 (es)
CA (1) CA2898040A1 (es)
MX (1) MX2015009037A (es)
WO (1) WO2014110580A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
CN105658281A (zh) * 2013-01-14 2016-06-08 三重创新公司 蜂蜜鼻冲洗
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
GB2535666B (en) 2014-04-30 2017-03-29 Matoke Holdings Ltd Antimicrobial compositions
US12239706B2 (en) 2015-11-30 2025-03-04 Seed Health, Inc. Method and system for protecting monarch butterflies from pesticides
IL262419B2 (en) 2016-04-19 2024-08-01 Canna B Cure Ltd A therapeutic composition containing enzyme-rich cannabis
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
FR3073737B1 (fr) * 2017-11-23 2020-10-09 Ainura Chodoeva La methode de traitement de la rhinosinusite
CN108567797A (zh) * 2018-03-26 2018-09-25 刘洪武 一种蚯蚓洗液
WO2020055547A2 (en) 2018-08-18 2020-03-19 Seed Health, Inc. Methods and compositions for honey bee health
CN111821368A (zh) * 2019-04-19 2020-10-27 鼻精灵(重庆)医疗科技有限公司 一种治疗鼻炎的组合物及含该组合物的鼻炎膏
CN112773764A (zh) * 2019-11-11 2021-05-11 鼻精灵(重庆)医疗科技有限公司 一种护鼻水
EP4061337B1 (en) * 2019-11-18 2024-07-31 Otosan S.r.l. Soluble preparation for nasal douches, corresponding nasal irrigation kit and operating procedure for carrying out nasal douches
US20230118955A1 (en) * 2020-04-06 2023-04-20 ManukaMed Limited Partnership Viral treatments involving manuka honey and components thereof
US20210315849A1 (en) * 2020-04-10 2021-10-14 Pacific Sinus Solutions LLC Compositions and methods for treating one or more ailments with a nasal rinse comprising n-acetylcysteine
CN111956667A (zh) * 2020-08-26 2020-11-20 北京达熙生物科技有限公司 多功能干细胞外泌体和间充质干细胞裂解物在制备治疗过敏性鼻炎药物中的应用
AU2022200728A1 (en) * 2022-02-03 2023-08-17 HAGGART, Ethan Tobias Grey Nasal spray formula for the prevention of contracting COVID19 and DELTA and Omnicom.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919956A (en) * 1985-01-17 1990-04-24 Ogilvie Mills, Inc. Methods for drying honey and molasses
DE4022058C2 (de) * 1990-07-11 1996-05-23 Oetker Nahrungsmittel Honigpulver und Verfahren zu seiner Herstellung
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
GB2347859B (en) * 1999-03-19 2004-02-25 Yasin Nazir Karim Yakub Herbal compositions
AU2007266260B2 (en) * 2006-05-31 2012-07-19 Medihoney Pty Ltd Medicinal compositions containing honey
JP2010095454A (ja) * 2008-10-14 2010-04-30 Cyclochem:Kk 抗菌組成物
US20120021060A1 (en) * 2010-07-21 2012-01-26 Amin Ramzanali Javer Honey Compositions and Uses Thereof
US8709505B2 (en) * 2011-02-14 2014-04-29 Juliet Agatha Boghossian Therapeutic rinse in a self-heating package
WO2012118535A1 (en) * 2011-03-01 2012-09-07 Quorum Innovations, Llc Materials and methods for treating conditions associated with pathogenic biofilm
US20120294952A1 (en) * 2011-05-18 2012-11-22 Zarbees, Inc. Antitussive compositions and methods
CN105658281A (zh) * 2013-01-14 2016-06-08 三重创新公司 蜂蜜鼻冲洗

Also Published As

Publication number Publication date
WO2014110580A1 (en) 2014-07-17
CA2898040A1 (en) 2014-07-17
EP2943252A1 (en) 2015-11-18
US20140199266A1 (en) 2014-07-17
JP2016505022A (ja) 2016-02-18
US20150297644A1 (en) 2015-10-22
CN105658281A (zh) 2016-06-08
AU2014205065A1 (en) 2015-07-30
US20150182563A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
MX2015009037A (es) Enjuague nasal con miel.
PH12015501703A1 (en) Trifluormethyl-substituted ring-fused pyrimidines and use thereof
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
PH12014501595A1 (en) Substituted annulated pyrimidines and triazines, and use thereof
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
MX2019008122A (es) Derivados de aminas heterociclicas que inhiben la transduccion de se?al mediada por cinasa asociada con el receptor de interleucina-1.
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
IN2015DN01156A (es)
MX2015010125A (es) Derivados de piridazinona-amidas.
CN104812762A8 (en) Substituted annulated pyrimidines and triazines, and use thereof
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
EP2827869A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ITS ANALOGUES INCLUDING MESOINDIGO
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
IN2014DN06104A (es)
UA116239C2 (uk) Нові похідні піридину
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
EA201600096A1 (ru) Бензил-1н-пиразол[3,4-b]пиридины и их применение
UA115357C2 (uk) Похідні піридин-4-ілу
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
IN2013CH04330A (es)
WO2015024992A3 (en) Treatment of asthma
TN2014000085A1 (en) Substituted annellated pyrimidine and the use thereof